Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00938522

Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention — PRECEDE  

Angioplasty, Transluminal, Percutaneous Coronary Clinical Trial

Official title:
PREtreatment of Cilostazol Loading in Elective Percutaneous Coronary Intervention to Decrease Adverse Events

Clinical Trial Summary

The purpose of this study is to investigate the effect of cilostazol loading before planned PCI on major adverse cardiac and cerebrovascular events in patients with coronary artery disease.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

  • Angioplasty, Transluminal, Percutaneous Coronary
Clinical Trial Details
NCT number NCT00938522
Study type Interventional
Source Samsung Medical Center
Contact Hyeon-Cheol Gwon, MD, PhD
Phone 82-2-3410-3418
Email hc.gwon@samsung.com
Status Not yet recruiting
Phase Phase 4
Start date July 2009
Completion date October 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01179126 - Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease Phase 3
Completed NCT01174433 - Safety Study to Assess the FEasibility of Use of the TRYTON Bifurcation Coronary Stent System (SAFE-TRY) Phase 1/Phase 2
Completed NCT00133731 - The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention Phase 2
Completed NCT01004575 - Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease N/A
Recruiting NCT00500279 - Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial Phase 4
Completed NCT00345501 - Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention Phase 2/Phase 3
Completed NCT00269893 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty Phase 3
Completed NCT00398463 - Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance Phase 4
Completed NCT00356044 - Arterial Access for Coronary Intervention in Myocardial Infarction Phase 4
Completed NCT00269906 - A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty Phase 3
Not yet recruiting NCT03047772 - Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients Phase 2
Completed NCT02039739 - Orsiro™ Drug Eluting Stent in Routine Clinical Practice
Completed NCT01241903 - Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions Phase 1
Completed NCT00574691 - ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU Phase 1
Active, not recruiting NCT02200783 - Randomized Comparison of Radiological Exposure With TRIPTable® in Patients With Acute Coronary Syndromes N/A
Terminated NCT02039713 - DESyne in Routine Clinical Practice
Recruiting NCT00637104 - European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent Phase 2/Phase 3
Completed NCT00533156 - Plug Arterial Closure System (PACS, 7F) Phase 2
Completed NCT00610870 - Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention N/A
Completed NCT00390585 - Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) Phase 4